| Product Code: ETC10939625 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Suriname vaccine import market saw significant growth in 2024, with top exporters being Brazil, India, USA, Netherlands, and France. The market concentration, as measured by the HHI, increased from high to very high in 2024, indicating a more consolidated market. The compound annual growth rate (CAGR) from 2020 to 2024 was a robust 10.35%, with a remarkable growth rate of 111.98% from 2023 to 2024. This data suggests a rapidly expanding market with key players dominating the vaccine import landscape in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Vaccine Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Vaccine Market - Industry Life Cycle |
3.4 Suriname Vaccine Market - Porter's Five Forces |
3.5 Suriname Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Suriname Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Suriname Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Suriname Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Suriname Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Vaccine Market Trends |
6 Suriname Vaccine Market, By Types |
6.1 Suriname Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Suriname Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Suriname Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Suriname Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Suriname Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Suriname Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Suriname Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Suriname Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Suriname Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Suriname Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Suriname Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Suriname Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Suriname Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Suriname Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Suriname Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Suriname Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Suriname Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Suriname Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Suriname Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Suriname Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Suriname Vaccine Market Import-Export Trade Statistics |
7.1 Suriname Vaccine Market Export to Major Countries |
7.2 Suriname Vaccine Market Imports from Major Countries |
8 Suriname Vaccine Market Key Performance Indicators |
9 Suriname Vaccine Market - Opportunity Assessment |
9.1 Suriname Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Suriname Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Suriname Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Suriname Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Suriname Vaccine Market - Competitive Landscape |
10.1 Suriname Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Suriname Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here